Poster Abstract Session:
149. New Approaches to Anti-Viral Therapy
Saturday, October 22, 2011: 11:45 AM-1:45 PM
Room: Poster Hall B1

Learning Objectives:


Target Audience: Academicians

Topical Category: V. Virology including clinical and basic studies of viral infections, including hepatitis

Tracks: Pediatric ID, Adult ID


Nitazoxanide, a Novel Potential Anti-Influenza Drug, Acting in Synergism with Neuraminidase Inhibitors
Giuseppe Belardo, PhD ; Simone La Frazia, PhD ; Orlando Cenciarelli, MS ; Stefania Carta, PhD ; Jean-Francois Rossignol, MD, FRCPath, PhD, FRSC ; M. Gabriella Santoro, PhD

Dynasore Blocks HSV Capsid Formation, Viral Egress and Cell-to-Cell Spread: Novel Strategy to Prevent Primary and Reactivating HSV Infection
Mascha Mues, MD ; Natalia Cheshenko, PhD ; Duncan W. Wilson, PhD ; Leslie Gunther-Cummins ; Betsy C. Herold, MD, FIDSA

Clinical Experience with Intravenous Zanamivir for Influenza Treatment under an Emergency IND program in the United States
Kirk Chan-Tack ; Arlene Gao ; Amalia Himaya ; Elizabeth Thompson ; Mary Singer ; Timothy Uyeki, MD ; Debra Birnkrant

Virologic Analysis of Influenza Viruses after Therapy with a Single Intramuscular (IM) Dose of the Neuraminidase Inhibitor (NAI) Peramivir (PVR) Versus Placebo (PBO) in Patients with Influenza in the Outpatient (OP) Setting
George Atiee, MD ; Allan Laughlin, MD ; Guy Tellier, MD ; Phil Collis, PhD ; William Alexander, MD ; John Wise, MD ; Amy Flynt, PhD ; Jaime Hernandez, MD

Estimation of the Reproduction Number of Pandemic Influenza A(H1N1) 2009 from Antiviral Agent Consumption
Dong Han Lee, MD, MPH. ; Dae Young Kang, PhD ; Chang Soo Kim, MD, PhD ; Jeehyun Lee, PhD ; Woo Joo Kim, MD ; Min-Sun Song, PhD ; Sang Sook Shin ; Byung Guk Yang, MD, PhD ; Byung Yool Jun, MD, PhD ; Jong Koo Lee, MD, PhD ; Il Suh, MD, PhD

Utility of Host Genetics to Individualise Hepatitis C (HCV) Treatment in HIV/HCV Co-infection
Daire O'Shea, MB, MRCPI ; Ciara Keane ; Gillian Farrell ; Clair Gardiner, PhD, FTCD ; Colm Bergin, MD, FRCPI

Controlled Trial of High-Dose Intravenous  Methylprednisolone for Hantavirus Cardiopulmonary Syndrome (HCPS) in Chile
Pablo Vial, MD ; Francisca Valdivieso, MD ; Marcela Ferres, MD, MPH ; Raul Riquelme, MD ; M Luisa Rioseco, MD ; Mario Calvo, MD ; Constanza Castillo, MD ; Ricardo Diaz, MD ; Luis Scholz, MD ; Analia Cuiza, RN ; Edith Belmar, RN ; Carla Hernandez, RN ; Sang-Joon Lee, PhD ; Gregory Mertz, MD

CME Credits:

ACPE Credits:

ACPE Number:

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.